Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesChange in TaxesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares IssuedShares RepurchasedShort-Term Debt issuancesShort-Term Debt repayments
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueDepreciation & Amortization (IS)EBIATGross ProfitLeasesLong-Term Debt IssuancesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetReceivables RefundsShares IssuedShares OutstandingShares OutstandingShares RepurchasedShort-Term Debt issuancesShort-Term Debt repaymentsWages, Salaries and Other
Ratios

Nutex Health (NUTX) Short-Term Debt repayments (2016 - 2026)

Nutex Health (NUTX) has disclosed Short-Term Debt repayments for 10 consecutive years, with $594000.0 as the latest value for Q1 2026.

  • For Q1 2026, Short-Term Debt repayments rose 103.42% year-over-year to $594000.0; the TTM value through Mar 2026 reached $8.2 million, up 359.4%, while the annual FY2025 figure was $7.9 million, 277.92% up from the prior year.
  • Short-Term Debt repayments hit $594000.0 in Q1 2026 for Nutex Health, down from $4.6 million in the prior quarter.
  • Across five years, Short-Term Debt repayments topped out at $4.6 million in Q4 2025 and bottomed at -$1000.0 in Q2 2024.
  • Average Short-Term Debt repayments over 5 years is $883528.4, with a median of $408500.0 recorded in 2024.
  • Year-over-year, Short-Term Debt repayments soared 335564.34% in 2024 and then crashed 50.92% in 2025.
  • Nutex Health's Short-Term Debt repayments stood at $26948.0 in 2022, then plummeted by 98.94% to $286.0 in 2023, then skyrocketed by 335564.34% to $960000.0 in 2024, then surged by 375.42% to $4.6 million in 2025, then crashed by 86.99% to $594000.0 in 2026.
  • According to Business Quant data, Short-Term Debt repayments over the past three periods came in at $594000.0, $4.6 million, and $3.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.